Posted in ‘thepharmaletter.com’ 19 November 2010 The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for drug giant Merck & Co’s (NYSE: MRK) Gardasil ([Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant) for the prevention of anal cancer and […]
Many Fail to Finish HPV Series as Recommended
By: Michael Smith, North American Correspondent, MedPage Today 13 December 2010 Many girls and young women may not be completing all three doses of the quadrivalent human papillomavirus vaccine in a timely fashion, researchers reported. In a single-institution retrospective analysis, only 14% of girls and young women completed all three doses within seven months […]
Assessing the effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer: perspectives from Germany
By: Professor Martina Doren Originally published February 2010 For approximately 2 years now, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines licensed in many countries. However, human papillomavirus(HPV) vaccines differ from existing others, as the former target a […]
FDA Reviewers Endorse Gardasil for Anal Cancer Prevention
By: Emily P. Walker 15 November 2010 WASHINGTON — Merck’s quadrivalent human papillomavirus recombinant vaccine, Gardasil, appears safe and effective at preventing anal cancer in males and females ages 9 to 26, FDA reviewers said. The vaccine was approved in 2006 to treat genital warts and cervical, vulvar, and vaginal cancer in females ages 9 […]
HPV Vaccine Side Effects as Expected
Posted in ‘Prescription Cancer Drugs’ 10 October 2010 Side effects of the quadrivalent human papillomavirus vaccine (Gardasil) have been pretty much what researchers expected, the CDC and FDA reported, although there were enough instances of of fainting and blood clots reported to worry critics. With more than 23 million doses of the vaccine distributed, most […]
